Methods of treating central nervous system disorders via administration of nanoparticles… Grant US-11944708-B2 United States of America 02 Apr 2024
Polynucleotides encoding optimized variants of anti-VEGF antibodies Grant US-10906968-B2 United States of America 02 Feb 2021
Optimized variants of anti-vegf antibodies and methods of use thereof in treatment Grant US-10899828-B2 United States of America 26 Jan 2021
Pharmaceutical formulation for use in spinal fusion Grant US-10589001-B2 United States of America 17 Mar 2020
Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing… Grant US-10072075-B2 United States of America 11 Sep 2018
Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis Grant US-9896499-B2 United States of America 20 Feb 2018
PARTICLES FOR DELIVERY OF PROTEINS AND PEPTIDES Application WO-2018026833-A1 World Intellectual Property Organisation (WIPO) 08 Feb 2018
VEGFR-3 ligand binding molecules and uses thereof Grant US-9745558-B2 United States of America 29 Aug 2017
Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and… Application US-9388239-B2 United States of America 12 Jul 2016
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Grant US-9260526-B2 United States of America 16 Feb 2016
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Grant US-8940695-B2 United States of America 27 Jan 2015
GM-CSF cosmeceutical compositions and methods of use thereof Grant US-8673859-B2 United States of America 18 Mar 2014
Supplemented matrices for the repair of bone fractures Grant US-8575101-B2 United States of America 05 Nov 2013
Materials and methods involving hybrid vascular endothelial growth factor DNAs and… Grant US-8278098-B2 United States of America 02 Oct 2012
PDGF fusion proteins incorporated into fibrin foams Grant US-8226942-B2 United States of America 24 Jul 2012
Transgenic mice expressing humanized VEGF Application US-8110720-B2 United States of America 07 Feb 2012
Compositions and methods related to erythropoietin Grant US-8084424-B2 United States of America 27 Dec 2011
Modified VEGF-A with improved angiogenic properties Grant US-8025886-B2 United States of America 27 Sep 2011
Materials and methods involving hybrid vascular endothelial growth factor DNAs and… Grant US-7902149-B2 United States of America 08 Mar 2011
Inhibitors of angiopoietin-like 4 protein, combinations, and their use Grant US-7740846-B2 United States of America 22 Jun 2010
Compositions and methods for liver growth and liver protection Grant US-7709455-B2 United States of America 04 May 2010
Compositions and methods for liver growth and liver protection Grant US-7700571-B2 United States of America 20 Apr 2010
Growth factor modified protein matrices for tissue engineering Grant US-7601685-B2 United States of America 13 Oct 2009
Materials and methods involving hybrid vascular endothelial growth factor DNAs and… Grant US-7566566-B2 United States of America 28 Jul 2009
Growth factor modified protein matrices for tissue engineering Grant US-7247609-B2 United States of America 24 Jul 2007
FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Grant US-7034105-B2 United States of America 25 Apr 2006